Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release Jan 04 2021

· Issued by Sun Pharmaceutical Industries Limited

Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".

View Attachment

6ix hasn’t read this filing yet.

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

Later from Sun Pharmaceutical Industries

All Sun Pharmaceutical Industries news releases